Global medical technology firm with diversified therapeutic portfolio Strong institutional backing reflects broad market ...

Medtronic (NYSE: MDT) made a significant neurovascular play earlier this month when it agreed to acquire Scientia Vascular.

Medtronic strengthens neurovascular segment with advanced guidewire technologies; Scientia Vascular enhances complex stroke ...

Medical device company Medtronic plc. (NYSE:MDT) recently revealed that it has entered into a definitive agreement to acquire Affera, a medical technology company. The financial terms of the deal have ...

Medtronic plc (NYSE:MDT) is included among the 14 Quality Stocks with Highest Dividends. On March 10, Medtronic plc (NYSE:MDT) announced that it had agreed to acquire Scientia Vascular for about $550 ...

By Sahil Pandey March 10 (Reuters) - Medical device maker Medtronic said on Tuesday it would buy U.S.-based Scientia Vascular ...

Medtronic ended its fiscal year with nominal sales growth and a steep profit drop, but analysts who cover the medical device company are confident a windfall is ahead, thanks to a strong lineup of ...

In early March 2026, Medtronic reported stronger-than-expected Q3 2026 results with 6% year-over-year organic revenue growth ...

Medtronic's diabetes care unit has grown faster than the rest of its business in recent years. However, the company decided to spin off this segment into a stand-alone corporation. Still, Medtronic ...

An extensive review of a much-scrutinized Medtronic, Inc., “bone-growth” product found that the product provides little to no benefits over more typical treatments. Fridley-based Medtronic, the ...

Medtronic has delivered a track record of earnings growth -- and recently beat earnings expectations even in a difficult economy. Still, the company may continue to face some headwinds in the coming ...